GO
Loading...

Government Agencies

More

  • NEW YORK, Dec 13- Wall Street rose modestly at the open on Friday, putting the S&P 500 on track to snap a three-day decline, though market participants remained cautious ahead of a Federal Reserve policy meeting next week.

  • *Producer prices fall 0.1 percent in November. WASHINGTON, Dec 13- U.S. producer prices fell for a third straight month in November, pointing to a lack of inflation pressure that could give the Federal Reserve pause as it weighs the future of its monthly bond purchases.

  • U.S. House passes bill for $633 bln in defense spending. NEW YORK, Dec 13- Wall Street was set for a higher open on Friday, poised to bounce back after a three-day decline, though market participants remained cautious ahead of a Federal Reserve policy meeting next week. Federal Reserve could decide to start scaling back stimulus at its policy meeting on Dec. 16-17.

  • WASHINGTON, Dec 13- U.S. producer prices fell for a third straight month in November, pointing to a lack of inflation that could give the Federal Reserve pause as it weighs the future of its monthly bond purchases.

  • *U.S. House passes bill for $633 bln in defense spending. NEW YORK, Dec 13- U.S. stock index futures edged higher on Friday, rebounding after a three-day decline on Wall Street, though market participants remained cautious ahead of a Federal Reserve policy meeting next week.

  • *AstraZeneca shares gain 2.2 percent. Dec 13- A new type of diabetes drug from Bristol-Myers Squibb and AstraZeneca has been endorsed by U.S. medical experts, two years after it was rejected by regulators because of safety concerns.

  • Bristol-Myers Squibb is developing the drug, which is already approved in Europe, in partnership with AstraZeneca. The FDA typically follows the advice of its advisory panels, but is under no obligation to do so.

  • *Libya aims to restart 3 eastern oil ports on Sunday. SINGAPORE, Dec 13- Brent crude held above $108 a barrel on Friday as traders eyed a restart of ports in eastern Libya while also looking ahead to next week's Federal Reserve meeting for any changes to its massive stimulus programme.

  • *Libya aims to restart 3 eastern oil ports on Sunday. SINGAPORE, Dec 13- Brent crude held above $108 a barrel on Friday as traders eyed a restart of ports in eastern Libya while also looking ahead to next week's Federal Reserve meeting for any changes to its massive stimulus programme.

  • SINGAPORE, Dec 13- London copper was set to close higher for the third week in four on Friday as a shortage of refined metal in the physical market underpinned prices, but prospects the Federal Reserve could soon trim its commodity-friendly stimulus dragged.

  • NYMEX-U.S. oil edges down towards $97 on Fed jitters Thursday, 12 Dec 2013 | 7:56 PM ET

    *President Barack Obama's campaign for Congress to hold off on new sanctions over Iran's nuclear programme won a key endorsement on Thursday when the chairman of the U.S. Senate Banking Committee rejected tightening measures against Iran now.

  • Bristol-Myers is developing the drug, which is already approved in Europe, in partnership with AstraZeneca Plc. The FDA typically follows the advice of its advisory panels, but is under no obligation to do so.

  • *VIX closes at highest level since mid-October. NEW YORK, Dec 12- U.S. stocks fell on Thursday as retail sales rose solidly in November, adding to signs the economy is strong enough for the Federal Reserve to begin reducing the pace of monetary stimulus.

  • *SPDR Gold Trust holdings drop, investment demand lags. NEW YORK/ LONDON, Dec 12- Gold prices fell 2 percent on Thursday as upbeat U.S. retail sales data boosted the dollar and stoked expectations that the Federal Reserve could reduce its bond-buying stimulus soon. Silver slid 4 percent, while platinum group metals also fell sharply.

  • Yen could be used to fund carry trades as Fed tapers Thursday, 12 Dec 2013 | 4:00 PM ET

    TOKYO, Dec 13- The Bank of Japan's commitment to ultra-easy monetary policy has revived the appeal of the yen to fund investments in higher-yielding assets, though analysts and market participants say the so-called yen carry trade has yet to catch fire.

  • NEW YORK, Dec 12- U.S. stocks dipped on Thursday as retail sales rose solidly in November, adding to signs the economy is strong enough for the Federal Reserve to begin reducing the pace of monetary stimulus. "Year-end activity is clouding reactions to some economic news," said Drew Wilson, an analyst at Fenimore Asset Management in Cobleskill, New York.

  • U.S. FDA warns against nipple test for breast cancer Thursday, 12 Dec 2013 | 3:23 PM ET

    The Food and Drug Administration, in a statement to healthcare professionals, said it is concerned that women will believe misleading claims about a nipple aspirate test and not get mammograms or other needed breast imaging tests or biopsies.

  • FDA panel says Merck's allergy drug effective Thursday, 12 Dec 2013 | 3:08 PM ET

    Dec 12- A panel of experts advising the U.S. Food and Drug Administration said an oral drug made by Merck& Co was effective in treating grass pollen allergy but expressed concerns about the drug's safety in children. It is sold as Grazax in Europe by Merck's partner ALK Abello.

  • *SPDR Gold Trust holdings drop, investment demand lags. NEW YORK/ LONDON, Dec 12- Gold prices fell two percent on Thursday as upbeat U.S. retail sales data boosted the dollar and stoked expectations that the Federal Reserve could reduce its bond-buying stimulus soon.

  • NEW YORK, Dec 12- The dollar rose and global equity markets slipped to a one-month low on Thursday after stronger-than-expected U.S. retail sales data added to jitters about when the Federal Reserve will start trimming its stimulus.

Most Popular Video

Wednesday, 16 Apr 2014 | 7:15 AM ET

Anthony Polini, Raymond James analyst, breaks down the big bank's quarterly numbers. It looks like they are doing a good job at reducing core operating expenses, says Polini.

Wednesday, 16 Apr 2014 | 6:36 AM ET

Thomas Digenan, UBS, and Jeffrey Saut, Raymond James, discuss how to play the market's volatility.

Wednesday, 16 Apr 2014 | 4:40 AM ET

Bitcoin. Digital gold rush or a shadowy tool empowering criminals on the dark web? What is really driving The Bitcoin Uprising? CNBC's Mary Thompson takes an in-depth look at this emerging digital currency by speaking to the bitcoin faithful, who believe the open source currency will upend the global financial system, as well as those who believe bitcoin is an easily manipulated tool that empowers criminals, hackers and drug barons in the dark online underworld. Although the future of bitcoin is uncertain, The Bitcoin Uprising sheds much needed light on the speculative currency and the future of money.